Dr. Ginger Jean Gardner, MD

Dr. Gardner practices at Memorial Sloan Kettering Cancer Center in New York, New York, part of Memorial Sloan Kettering Cancer Center.

Dr. Gardner's NPI, 1144263765, was assigned on June 13, 2006. Dr. Gardner graduated from Boston University School Of Medicine in 1996. Dr. Gardner holds New York license 224188.

Dr. Gardner's primary practice is Memorial Sloan Kettering Cancer Center, at 1275 York Avenue, New York, NY 10065.

Dr. Gardner's primary practice is Memorial Sloan Kettering Cancer Center in New York, New York, part of Memorial Sloan Kettering Cancer Center. The medical group on file is Memorial Sloan Kettering Cancer Center (MSK), Department of Surgery. Dmand AI also links Dr. Gardner to 2 more medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Gardner practices. Vendor and product names are available with a free account.

Gynecologic oncology is Dr. Gardner's primary specialty in the NPI Registry, under taxonomy code 207VX0201X. Dr. Gardner is board certified in gynecologic oncology by the American Board of Obstetrics and Gynecology. Dmand AI has Dr. Gardner's licenses on file in 3 states: New York, New Jersey and Maryland.

Dmand AI lists abdominal adhesion surgery, hysterectomy and ovarian cyst among the conditions Dr. Gardner treats.

CMS data shows 215 Medicare services from Dr. Gardner across 4 procedure codes in 2024, for 119 Medicare patients. Medicare paid $18,441 for them. Every service was in an office.

CMS counts 119 Medicare patients who saw Dr. Gardner in 2024. The largest group is 65 to 74, with 65 patients. 67% of them have high cholesterol, and 63% have high blood pressure. 15% are also on Medicaid. Their average risk score is 1.80, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Gardner's median patient age at 68, with 99% women.

In 2020, Dr. Gardner wrote 11 Medicare Part D claims. Every claim was for a generic drug. They cover 1 drug, with $202 in total drug cost. In 2019, CMS named 14 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 86 out of 100 for Dr. Gardner for performance year 2024, reported as part of a group. Dr. Gardner accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Gardner as offering telehealth. CMS counts 20 procedures of removal of the uterus by Dr. Gardner, more than 93% of the clinicians it reports for that procedure.

Colonoscopy: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 187 papers to Dr. Gardner, published from 2005 to 2025. 2020 was the busiest year, with 27. The most frequent topics are Ovarian Neoplasms, Cytoreduction Surgical Procedures and Carcinoma, Ovarian Epithelial. Dr. Gardner has published most often in Gynecol Oncol. Dr. Gardner's most frequent co-authors are Yukio Sonoda, MD, Dennis S. Chi, MD and Nadeem R. Abu-Rustum, MD.

Dmand AI links Dr. Gardner to 2 clinical trials. 2 are still active or recruiting. Conditions studied include Fallopian Tube Diseases, Ovarian Neoplasms and Fallopian Tube Neoplasms. Memorial Sloan Kettering Cancer Center sponsors the most, 2.

CMS Open Payments shows 19 general payments to Dr. Gardner from 9 drug and device companies from 2017 to 2025. Consulting fees make up the largest share, 76% of the total. Eisai Inc. paid the most, $6,875.

Dmand AI lists 1 award for Dr. Gardner.

Dr. Gardner graduated from Boston University School Of Medicine in 1996. Dr. Gardner is a member of American College of Obstetricians and Gynecologists.

Dr. Gardner is in network with 13 carriers, including Aetna, Excellus BlueCross BlueShield and United Healthcare. PPO plans come from the most carriers, 8. Check the plan with the practice before a visit.